Clinical Trial Update: A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized double-blind placebo-controlled study for painful diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED